|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/425 | |
| A61P 35/00 | |||
| A61K 31/4745 | |||
| A61K 31/505 | |||
| A61K 31/282 | |||
| A61K 31/337 | |||
| A61K 31/70 |
| (11) | Patento numeris | 1545519 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03792573.2 |
| Europos patento paraiškos padavimo data | 2003-08-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-06-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-03-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2003/003550 |
| Data | 2003-08-07 |
| (87) | Numeris | WO 2004/017964 |
| Data | 2004-03-04 |
| (30) | Numeris | Data | Šalis |
| 404461 P | 2002-08-19 | US |
| (72) |
BEEBE, Jean, Saccuzzo, US
FERRANTE, Karen, Jean, US
JANI, Jitesh, Pranlal, US
SCHAEFFER, Tracey, Lee, US
HEALEY, Diane, Ingeborg, US
O`LEARY, James, John, US
|
| (73) |
OSI Pharmaceuticals, Inc.,
41 Pinelawn Road, Melville, NY 11747,
US
Pfizer Inc., 235 East 42nd Street, New York, NY 10017-5755, US |
| (54) | COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES |
| COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES |